Intestinal Permeability: Evidence, Uncertainty and Clinical Relevance

“Leaky gut” is one of the most searched health terms online and one of the most contested in medicine. Many patients arrive convinced that it explains their fatigue, joint pain, skin problems or brain fog. Many clinicians dismiss it as pseudoscience. Both reactions miss something. Intestinal permeability is a real, measurable physiological property that changes in several well defined conditions. What is uncertain, and in many cases unsupported, is the claim that increased permeability is a common hidden cause of chronic disease. Holding that distinction clearly is essential for credible practice.

The gut barrier

The intestinal barrier separates the body from a lumen full of food antigens, microbes and their products. It has several layers:

• a mucus layer, thicker in the colon, which keeps most bacteria at a distance from the epithelium;
• antimicrobial peptides and secretory IgA;
• a single layer of epithelial cells, joined by tight junctions, protein complexes that regulate the passage of water, ions and small molecules between cells;
• the underlying immune system, which samples antigens and responds to those that breach the barrier.

The barrier is not meant to be impermeable. It must absorb nutrients, water and electrolytes, and it allows controlled sampling of antigens to maintain immune tolerance. Permeability is a regulated property, which increases and decreases in response to many signals.

Measuring permeability

The best established methods measure the urinary excretion of orally administered sugar probes, such as lactulose and mannitol. Larger molecules like lactulose cross mainly between cells, smaller ones like mannitol mainly through cells, so the ratio of their excretion reflects paracellular permeability in the small intestine. Other probes assess the colon. These tests are valuable in research but are not standardised for routine clinical use, and their results vary with the protocol and laboratory.

Blood markers have been proposed but have significant limitations. Zonulin, a protein described as a regulator of tight junctions, has been widely marketed as a blood test for leaky gut. Investigators found that a commonly used commercial zonulin assay did not detect zonulin itself but other related proteins, casting doubt on the results obtained with it. Markers of bacterial translocation, such as lipopolysaccharide binding protein, are influenced by many factors. None of these tests is validated for diagnosing a clinical condition in individual patients.

Where increased permeability is well established

Increased permeability has also been reported in association with type 1 diabetes, fatty liver disease, obesity and some psychiatric and autoimmune conditions. In these, it is often unclear whether altered permeability is a cause, a consequence or a parallel feature of the disease.

The claim that is not established

The popular concept of leaky gut syndrome holds that increased permeability is a common, often undiagnosed condition that allows toxins, microbes and food particles into the bloodstream, driving systemic inflammation and causing a broad range of symptoms and diseases. Proponents recommend testing, elimination diets and supplement protocols to heal the gut.

The evidence does not support this as a general explanation. Leaky gut syndrome is not a recognised diagnosis, the tests used to identify it are largely unvalidated, and it has not been shown that treating increased permeability improves the conditions it is said to cause. It remains a hypothesis, one that is biologically plausible in some settings and worth researching, but not a diagnosis to give patients.

Why the idea resonates

It is worth understanding why the concept is so appealing. It offers a single, unifying explanation for multiple unexplained symptoms. It points to the gut, which many patients intuitively feel is involved. And the interventions often recommended alongside it, such as removing ultra processed food, reducing alcohol, stopping unnecessary NSAIDs, improving sleep and eating more fibre, are frequently beneficial for other reasons. Patients may improve, and attribute the improvement to healing a leaky gut, when the benefit came from those broader changes.

What can be done

For patients with symptoms they attribute to leaky gut, a constructive approach focuses on established causes and general gut health.

1. Assess for conditions with known effects on the barrier: coeliac disease serology while eating gluten, inflammatory markers and faecal calprotectin where indicated.
2. Remove known aggravating factors: unnecessary NSAIDs, excess alcohol.
3. Treat identified conditions: a gluten free diet in coeliac disease, specialist management of inflammatory bowel disease.
4. Support general gut health: a diverse, fibre rich diet, fermented foods if tolerated, adequate sleep and stress management.
5. Be cautious with supplement protocols. Glutamine, for example, improved symptoms in one trial of post infection irritable bowel syndrome with diarrhoea and increased permeability, but evidence for broader use is limited. Zinc, collagen and other popular products lack strong evidence for barrier repair in most people.
6. Avoid unvalidated tests that may lead to unnecessary restriction and cost.

Talking with patients

A respectful conversation acknowledges the patient’s experience and the reality of gut barrier science, while being honest about uncertainty. A practitioner might explain that the gut lining does become more permeable in some conditions, that researchers are studying whether this contributes to other diseases, that there is not yet a reliable test or treatment for leaky gut as a general condition, and that the most effective steps are to look for specific treatable causes and to build habits that support gut health. Many patients find this more reassuring than either dismissal or a confident diagnosis.

An illustrative case

A 37 year old man with fatigue, joint aches and bloating has been told by an online practitioner that he has leaky gut, based on a raised zonulin result, and has been following a restrictive diet with several supplements for 4 months with little change. He takes ibuprofen most days for his joints and drinks heavily at weekends.

His doctor checks coeliac serology, which is positive; a biopsy confirms coeliac disease. He starts a strict gluten free diet with a dietitian’s support, stops regular ibuprofen and reduces alcohol. His supplements are reviewed and mostly stopped. Over 6 months his bloating, fatigue and joint aches improve substantially. In his case there was indeed a barrier problem, but its cause was a specific, diagnosable condition that the zonulin test had not identified.

Keeping 2 ideas in view

Intestinal permeability is real, measurable and important in several diseases. Leaky gut syndrome, as a common hidden cause of chronic illness, is an unproven hypothesis. Practitioners who can hold both ideas at once can take patients’ concerns seriously, look for treatable causes and avoid the unvalidated tests and open ended protocols that too often follow.